Avedro Announces CE Mark for its Newest Riboflavin Formulations – Arlington Heights Daily Herald

Avedro, Inc., a global ophthalmic medical device and pharmaceutical company, has announced that it has expanded its portfolio of proprietary riboflavin formulations for corneal collagen cross-linking. When used in conjunction with Avedro’s KXL …